NOX1, expressed in vascular smooth muscle tissue and endothelial cells, is apparently an important target in diabetes-associated atherosclerosis considering that its inhibition significantly reduces ROS production and vasculopathy [8]. Here, NOX1 is linked to diabetes mellitus.